| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
48,591 |
43,616 |
$5.37M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,925 |
17,783 |
$2.22M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,288 |
7,798 |
$1.19M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12,884 |
11,375 |
$934K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,218 |
5,992 |
$775K |
| 80053 |
Comprehensive metabolic panel |
24,948 |
22,777 |
$638K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
6,217 |
1,736 |
$633K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,209 |
1,634 |
$559K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,406 |
2,275 |
$497K |
| 36415 |
Collection of venous blood by venipuncture |
20,532 |
17,517 |
$472K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,622 |
1,583 |
$392K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,880 |
3,748 |
$377K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,297 |
1,258 |
$365K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,836 |
2,836 |
$357K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,663 |
2,522 |
$325K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,170 |
2,101 |
$317K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,733 |
2,729 |
$303K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,315 |
2,150 |
$298K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
9,542 |
9,489 |
$294K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,616 |
2,588 |
$285K |
| 99442 |
|
2,385 |
2,125 |
$283K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,345 |
2,323 |
$266K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,075 |
1,814 |
$251K |
| 20610 |
|
955 |
915 |
$230K |
| 99215 |
Prolong outpt/office vis |
1,651 |
1,584 |
$221K |
| 87631 |
|
1,791 |
1,760 |
$220K |
| 51798 |
|
728 |
689 |
$206K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,558 |
1,558 |
$193K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,901 |
1,684 |
$193K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,620 |
1,613 |
$186K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,990 |
4,252 |
$180K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
9,873 |
9,132 |
$148K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,552 |
3,282 |
$145K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
612 |
583 |
$115K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
1,493 |
1,394 |
$114K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
440 |
426 |
$113K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,646 |
2,626 |
$107K |
| 81025 |
|
3,088 |
2,968 |
$105K |
| 80061 |
Lipid panel |
13,001 |
12,944 |
$105K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
598 |
594 |
$103K |
| 93976 |
|
372 |
370 |
$102K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,217 |
11,944 |
$100K |
| 99441 |
|
940 |
872 |
$92K |
| 36416 |
|
1,131 |
919 |
$84K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,947 |
1,943 |
$83K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,353 |
862 |
$80K |
| 96127 |
|
4,199 |
4,185 |
$77K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,559 |
9,492 |
$73K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,929 |
1,818 |
$71K |
| 99406 |
|
3,239 |
3,101 |
$67K |
| 97161 |
|
646 |
641 |
$63K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,393 |
3,012 |
$62K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
534 |
526 |
$62K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,674 |
2,652 |
$53K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,395 |
21,388 |
$53K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
353 |
344 |
$51K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
323 |
311 |
$43K |
| 90686 |
|
1,220 |
1,218 |
$43K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,873 |
1,869 |
$43K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
928 |
495 |
$36K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
290 |
289 |
$35K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
919 |
772 |
$33K |
| 90715 |
|
1,411 |
1,407 |
$32K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,705 |
3,615 |
$31K |
| 82607 |
|
2,466 |
2,460 |
$28K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
129 |
36 |
$28K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
810 |
807 |
$27K |
| 97016 |
|
587 |
217 |
$27K |
| 83880 |
|
979 |
929 |
$26K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
664 |
653 |
$25K |
| 84153 |
|
1,644 |
1,629 |
$25K |
| 86850 |
|
537 |
522 |
$22K |
| 81003 |
|
6,522 |
5,952 |
$21K |
| 82728 |
|
2,179 |
2,129 |
$21K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
400 |
377 |
$21K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
593 |
591 |
$18K |
| 84439 |
|
2,271 |
2,232 |
$18K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
530 |
529 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,660 |
6,048 |
$18K |
| 59025 |
Fetal non-stress test |
102 |
50 |
$17K |
| 90670 |
|
773 |
772 |
$17K |
| 99443 |
|
161 |
150 |
$15K |
| 86901 |
|
626 |
604 |
$15K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,361 |
1,353 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
483 |
474 |
$14K |
| 83655 |
|
1,051 |
1,042 |
$13K |
| 90723 |
|
596 |
595 |
$12K |
| 88142 |
|
423 |
419 |
$11K |
| 90647 |
|
547 |
547 |
$11K |
| 86900 |
|
626 |
604 |
$11K |
| G0378 |
Hospital observation service, per hour |
392 |
370 |
$11K |
| 93017 |
|
131 |
128 |
$10K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
24 |
24 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
3,540 |
3,428 |
$10K |
| 82803 |
|
578 |
520 |
$10K |
| 85027 |
|
3,507 |
3,354 |
$9K |
| 90734 |
|
390 |
390 |
$9K |
| 71250 |
|
92 |
92 |
$9K |
| 97162 |
|
71 |
71 |
$8K |
| 84702 |
|
1,297 |
1,020 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,195 |
2,127 |
$8K |
| 0352U |
|
202 |
194 |
$8K |
| 82570 |
|
1,882 |
1,832 |
$8K |
| 84481 |
|
910 |
903 |
$8K |
| 90688 |
|
313 |
312 |
$8K |
| 83540 |
|
1,991 |
1,955 |
$7K |
| 82043 |
|
1,529 |
1,519 |
$7K |
| 87632 |
|
330 |
317 |
$7K |
| 87077 |
|
1,953 |
1,880 |
$7K |
| 87070 |
|
2,955 |
2,878 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
108 |
108 |
$7K |
| 88174 |
|
252 |
252 |
$7K |
| 90651 |
|
156 |
156 |
$6K |
| 83550 |
|
1,702 |
1,667 |
$6K |
| 81001 |
|
5,004 |
4,670 |
$6K |
| 85610 |
|
2,333 |
1,961 |
$6K |
| 0012A |
|
141 |
141 |
$6K |
| 90710 |
|
265 |
264 |
$6K |
| 84207 |
|
200 |
200 |
$5K |
| 87186 |
|
1,925 |
1,856 |
$5K |
| 76770 |
|
28 |
28 |
$5K |
| 90671 |
|
198 |
198 |
$5K |
| 76830 |
Ultrasound, transvaginal |
218 |
218 |
$5K |
| 12001 |
|
12 |
12 |
$5K |
| 93000 |
|
2,274 |
2,105 |
$5K |
| 99385 |
|
39 |
39 |
$5K |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
217 |
217 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,814 |
3,798 |
$4K |
| 83735 |
|
3,062 |
2,713 |
$4K |
| 86618 |
|
331 |
331 |
$4K |
| 86803 |
|
604 |
601 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,004 |
2,794 |
$3K |
| 90661 |
|
134 |
134 |
$3K |
| 86140 |
|
1,352 |
1,299 |
$3K |
| 76536 |
|
142 |
139 |
$3K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
27 |
25 |
$3K |
| 96367 |
|
94 |
72 |
$3K |
| 71271 |
|
31 |
31 |
$2K |
| 80076 |
|
153 |
149 |
$2K |
| 73030 |
|
757 |
739 |
$2K |
| 99233 |
Prolong inpt eval add15 m |
19 |
12 |
$2K |
| 83690 |
|
3,828 |
3,530 |
$2K |
| 90633 |
|
86 |
86 |
$2K |
| 73630 |
|
741 |
715 |
$2K |
| 72100 |
|
251 |
248 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
13 |
13 |
$2K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
14 |
13 |
$1K |
| 87340 |
|
308 |
307 |
$1K |
| 94060 |
|
25 |
25 |
$1K |
| 90681 |
|
68 |
68 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,933 |
2,750 |
$1K |
| 90696 |
|
69 |
69 |
$1K |
| 86592 |
|
483 |
480 |
$1K |
| 73610 |
|
791 |
737 |
$1K |
| 76642 |
|
63 |
61 |
$1K |
| 82746 |
|
129 |
129 |
$1K |
| 84403 |
|
63 |
63 |
$1K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$1K |
| 0011A |
|
146 |
146 |
$1K |
| 87205 |
|
722 |
703 |
$1K |
| 85730 |
|
1,356 |
1,298 |
$1K |
| 85652 |
|
828 |
797 |
$1K |
| 73562 |
|
233 |
225 |
$992.04 |
| 87430 |
|
1,144 |
1,126 |
$962.11 |
| 87660 |
|
962 |
947 |
$939.02 |
| 84484 |
|
2,907 |
2,530 |
$930.46 |
| 88304 |
|
26 |
26 |
$911.93 |
| 87480 |
|
953 |
938 |
$903.10 |
| 85379 |
|
773 |
754 |
$900.17 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
126 |
123 |
$875.92 |
| 72110 |
|
117 |
116 |
$870.68 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
14 |
14 |
$847.40 |
| 87510 |
|
953 |
938 |
$813.33 |
| 90656 |
|
69 |
69 |
$789.63 |
| 86038 |
|
178 |
175 |
$726.90 |
| 73130 |
|
402 |
389 |
$697.41 |
| 87522 |
Neg quan hep c or qual rna |
15 |
14 |
$648.21 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
831 |
732 |
$622.58 |
| 73564 |
|
174 |
171 |
$603.12 |
| 71045 |
Radiologic examination, chest; single view |
1,335 |
1,285 |
$566.63 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
13 |
13 |
$537.22 |
| 97035 |
|
29 |
13 |
$531.42 |
| 93018 |
|
39 |
39 |
$495.18 |
| 86787 |
|
113 |
113 |
$472.52 |
| 86376 |
|
38 |
38 |
$441.81 |
| 82947 |
|
873 |
661 |
$420.93 |
| 0071A |
|
18 |
18 |
$400.00 |
| 82248 |
|
268 |
248 |
$389.01 |
| 86762 |
|
78 |
78 |
$381.04 |
| 83001 |
|
39 |
39 |
$371.60 |
| 86431 |
|
75 |
75 |
$344.08 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
57 |
57 |
$341.37 |
| 74018 |
|
140 |
134 |
$322.36 |
| 85018 |
|
332 |
328 |
$294.63 |
| 82784 |
|
37 |
37 |
$279.00 |
| 73502 |
|
88 |
87 |
$277.10 |
| 84703 |
|
822 |
799 |
$262.83 |
| 94726 |
|
12 |
12 |
$253.36 |
| 83605 |
|
1,214 |
1,099 |
$242.17 |
| 87040 |
|
422 |
389 |
$210.58 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,667 |
2,751 |
$186.08 |
| 93016 |
|
13 |
13 |
$184.95 |
| 86780 |
|
22 |
22 |
$178.64 |
| 84550 |
|
90 |
87 |
$159.42 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
108 |
100 |
$148.96 |
| 73110 |
|
124 |
114 |
$148.30 |
| 83002 |
|
12 |
12 |
$148.16 |
| 72050 |
|
28 |
28 |
$132.00 |
| 86800 |
|
13 |
13 |
$131.89 |
| 87081 |
|
109 |
107 |
$117.01 |
| 84146 |
|
13 |
13 |
$116.28 |
| 82962 |
|
366 |
235 |
$111.33 |
| 72070 |
|
12 |
12 |
$102.64 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,147 |
1,031 |
$101.60 |
| 90461 |
|
578 |
577 |
$95.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
245 |
237 |
$90.22 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,851 |
2,649 |
$79.07 |
| 86364 |
|
12 |
12 |
$76.78 |
| 84100 |
|
19 |
12 |
$70.42 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,189 |
6,768 |
$48.80 |
| 80320 |
|
663 |
600 |
$48.00 |
| 83615 |
|
29 |
27 |
$46.91 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
295 |
273 |
$45.45 |
| 80306 |
|
126 |
124 |
$44.44 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
243 |
232 |
$44.26 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
600 |
582 |
$42.52 |
| 73560 |
|
12 |
12 |
$36.00 |
| 80143 |
|
184 |
166 |
$29.46 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,209 |
1,127 |
$27.19 |
| 82950 |
|
43 |
42 |
$22.87 |
| 82550 |
|
42 |
39 |
$20.32 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
938 |
872 |
$17.23 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
205 |
205 |
$15.00 |
| J2704 |
Injection, propofol, 10 mg |
1,053 |
736 |
$14.26 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,807 |
2,541 |
$12.38 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
202 |
192 |
$11.03 |
| 80329 |
|
193 |
176 |
$10.76 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
729 |
613 |
$10.35 |
| 80179 |
|
196 |
177 |
$8.56 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
911 |
888 |
$6.90 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
793 |
708 |
$5.94 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
84 |
79 |
$5.68 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
479 |
419 |
$2.75 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
35 |
33 |
$2.53 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
185 |
179 |
$1.92 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
893 |
872 |
$0.97 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
150 |
149 |
$0.00 |
| 87147 |
|
27 |
27 |
$0.00 |
| 82077 |
|
389 |
357 |
$0.00 |
| 96376 |
|
170 |
163 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
14 |
12 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
143 |
126 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
20 |
12 |
$0.00 |
| 99024 |
|
17 |
14 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
28 |
26 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
191 |
172 |
$0.00 |
| 83721 |
|
96 |
96 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
13 |
12 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
76 |
76 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
75 |
73 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
46 |
37 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
12 |
12 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
27 |
13 |
$0.00 |
| 82948 |
|
12 |
12 |
$0.00 |